KIF26B Inhibitors

Chemical inhibitors of KIF26B exert their functional inhibition primarily through interference with microtubule dynamics, which are crucial for the motor activities of this kinesin-like protein. Paclitaxel, a well-known microtubule stabilizer, prevents microtubule disassembly, which can obstruct the normal function of KIF26B by impairing its ability to traverse along the microtubule tracks. Similarly, Peloruside A also stabilizes microtubules, creating a static environment that is not conducive to the motor function of KIF26B. In contrast, agents such as Vinblastine, Nocodazole, and Colchicine actively disrupt microtubule assembly. Vinblastine binds to tubulin dimers, inhibiting their polymerization and consequently preventing KIF26B from engaging with the microtubules. Nocodazole similarly impedes the polymerization process, while Colchicine binds tubulin with an inhibitory effect on its assembly into microtubules, collectively hampering the motor function of KIF26B. Furthermore, Podophyllotoxin and Griseofulvin directly inhibit microtubule assembly, which is an essential feature for the activity of KIF26B. Eribulin, with its unique mechanism of inhibiting the growth phase of microtubules without affecting the shortening phase, alters microtubule dynamics in a way that can interfere with KIF26B. Vincristine's binding to tubulin dimers also prevents microtubule assembly, adding another layer of obstruction to KIF26B's function. Monastrol, though primarily known as an inhibitor of the kinesin Eg5, suggests the possibility of similar small molecules that could inhibit KIF26B by altering its binding to microtubules. Parbendazole and Albendazole contribute to the functional inhibition of KIF26B by causing degenerative alterations in tubulin polymerization and microtubule organization, which are integral to the motor activity of KIF26B.